Tag: Health Care

Displaying 1 - 20 of 542 results.

Pages

Filtering by content type: Press Release

Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Abbott Laboratories’ $25 billion acquisition of St. Jude Medical, Inc. would likely be anticompetitive.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Bausch + Lomb parent company Valeant Pharmaceuticals International, Inc. illegally acquired Paragon Holdings I, Inc.
OFTACOOP, a Puerto Rico ophthalmologist cooperative, has agreed to settle Federal Trade Commission charges that its actions harmed competition. The complaint charges that  OFTACOOP – also known as Cooperativa de Médico Oftalmólogos de Puerto Rico –  unlawfully orchestrated an agreement among...
Mallinckrodt ARD Inc., formerly known as Questcor Pharmaceuticals, Inc., and its parent company, Mallinckrodt plc, have agreed to pay $100 million to settle Federal Trade Commission charges that they violated the antitrust laws when Questcor acquired the rights to a drug that threatened its...
The Federal Trade Commission announced today that it is hosting a workshop in Washington, DC on April 18, 2017, to examine competition, innovation, and consumer protection issues raised by hearing health and technology, particularly hearing aids and devices with similar functions and features.
Federal Trade Commission staff has submitted a comment to the Iowa Board of Physician Assistants supporting a regulatory proposal to define physician supervision of a physician assistant (PA), in response to a Board request for public comments.
Federal Trade Commission staff submitted a comment to the Delaware Board of Speech/Language Pathologists, Audiologists and Hearing Aid Dispensers on its proposed regulation that would allow telepractice in those fields but require an initial in-person evaluation.
The Federal Trade Commission is seeking public comment on proposed amendments to the Contact Lens Rule, as well as several other issues related to the Rule.
The Federal Trade Commission filed an amicus brief with the U.S. Court of Appeals for the First Circuit urging the court to reverse the district court’s dismissal of the complaint in Amphastar Pharmaceuticals, Inc. v. Momenta Pharmaceuticals, Inc.
“The FTC is pleased that the 7th Circuit rejected the district court’s geographic market findings, and we are looking forward to proving our case,” said Debbie Feinstein, Director of the FTC’s Bureau of Competition.
At a public hearing in Abingdon, Virginia, held today, FTC staff presented oral remarks to the Southwest Virginia Health Authority and the Virginia Department of Health summarizing staff’s analyses and conclusions that the cooperative agreement application submitted by Mountain States Health...
On September 9, 2016, the Federal Trade Commission and Department of Justice filed a joint amicus brief urging the U.S. Court of Appeals for the Fifth Circuit to dismiss an appeal by the Texas Medical Board of a district court decision holding that Board regulations restricting telehealth services...
The Federal Trade Commission will participate in a Twitter chat hosted by the Centers for Disease Control. The chat will include tips about healthy contact lens wear and care habits. The FTC will explain consumers’ rights under the Contact Lens Rule, including the right to get your prescription...
Federal Trade Commission staff submitted a comment to the Delaware Board of Dietetics/Nutrition regarding its proposed telehealth regulation that would require in-person initial evaluations of patients, and then allow licensed dietitians and nutritionists to determine whether to use telehealth...
After a public comment period, the Federal Trade Commission has approved a final order resolving the Commission’s complaint against Practice Fusion. In its complaint, the FTC charged that Practice Fusion misled consumers by soliciting reviews for doctors in connection with an online healthcare...
Federal Trade Commission staff submitted a comment to the Delaware Board of Occupational Therapy Practice on its proposed regulation that would likely facilitate the provision of occupational therapy services to Delaware consumers.
A health care scammer and his company, who tricked Spanish-speaking and other consumers seeking health insurance into buying phony medical discount cards, are banned from selling healthcare-related products, and from telemarketing, under court orders obtained by the Federal Trade Commission.
Practice Fusion, a cloud-based electronic health record company, has agreed to settle Federal Trade Commission charges it misled consumers by soliciting reviews for their doctors, without disclosing adequately that these reviews would be publicly posted on the Internet resulting in the public...
After a public comment period, the Federal Trade Commission has approved a final order resolving the Commission’s complaint against Henry Schein Practice Solutions, Inc., alleging the company falsely advertised the level of encryption it provided to protect patient data.

Pages